Known targets — ChEMBL curated mechanism
ADRB1ADRB2SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Propafenone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.79 |
| ▸ | ADRB1 known ✓ | P08588 | 1/20 | 0.79 |
| ▸ | SCN5A known ✓ | Q14524 | 1/20 | 0.79 |
| ▸ | ABCB1 | P08183 | 17/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.79 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.79 |
| ▸ | TSHR | P16473 | 2/20 | 0.79 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.79 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.79 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.79 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.79 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.79 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.79 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.79 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.79 |
| ▸ | HTR2A | P28223 | 1/20 | 0.79 |
| ▸ | HTR2C | P28335 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propafenone SCHEMBL16730120 | 0.89 | ABCB1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL27865 | 0.89 | ABCB1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL30416841 | 0.89 | ABCB1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL41413 | 0.89 | ABCB1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL29384899 | 0.88 | MEN1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL41412 | 0.88 | MEN1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL5529275 | 0.88 | MEN1 (1.00) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL1651012 | 0.87 | ABCB1 (0.96) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| SCHEMBL29419081 | 0.83 | ABCB1 (0.88) | ABCB1LMNACYP1A2CYP2D6CYP3A4 | |
| Propafenone SCHEMBL15539494 | 0.81 | ABCB1 (0.83) | ABCB1LMNACYP1A2CYP2D6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7867517-B2 | Oral pharmaceutical composition with improved bioavailability | FARMATRON, LTD. (GB) | 2011-01-11 | — | — | US | disclosed |
| US-7727551-B2 | Oral pharmaceutical compositions with modified release of the active ingredient | FARMATRON LTD. (GB) | 2010-06-01 | — | — | US | disclosed |
| EP-1401405-B1 | ORAL PHARMACEUTICAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY | FARMATRON LTD (GB) | 2005-08-31 | — | — | EP | disclosed |
| EP-1401501-B1 | ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT | FARMATRON LTD (GB) | 2005-08-24 | — | — | EP | disclosed |
| US-20040247666-A1 | Oral pharmaceutical composition with improved bioavailability | FARMATRON, LTD. (GB) | 2004-12-09 | — | — | US | disclosed |
| US-20040213844-A1 | Oral pharmaceutical compositions with modified release of the active ingredient | FARMATRON LTD. (GB) | 2004-10-28 | — | — | US | disclosed |
| EP-1401405-A1 | ORAL PHARMACEUTICAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY | Farmatron Ltd. (GB) | 2004-03-31 | — | — | EP | disclosed |
| EP-1401501-A1 | ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT | Farmatron Ltd. (GB) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003002151-A1 | ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT | FARMATRON LTD. (GB) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002101-A1 | ORAL PHARMACEUTICAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY | FARMATRON LTD. (GB) | 2003-01-09 | — | — | WO | disclosed |